Amgen: Institutional Investors Pile into Biotech Giant
Hussman Strategic Advisors Inc., a financial services firm, increased its stake in Amgen Inc. (NASDAQ:AMGN) by 60% during the second quarter.
The company now owns 8,400 shares of Amgen's stock, valued at $3,042,000, according to its most recent Form 13F filing with the SEC.
This is not an isolated incident, as several other institutional investors and hedge funds have also purchased or increased their stakes in Amgen during the second quarter.